Glucose-deprived tumor microenvironment activates AMP-activated protein kinase to drive adoptively transferred T helper 9 cell senescence.

Glucose deprivation in the tumor microenvironment activates AMPK, leading to Th9 cell senescence and reducing their therapeutic persistence in solid tumors.

• Why it matters: Understanding how nutrient scarcity affects Th9 cell survival is crucial for improving adoptive cell therapy outcomes against solid tumors, where the tumor microenvironment often limits immune cell persistence.
• What they did: The study examined the effects of glucose depletion on Th9 cells, revealing that low glucose activates AMPK and downstream ZAK-NF-κB pathways, which suppress IL-9 production and induce cell senescence.
• The result: Targeting ZAK restored Th9 cell function and enhanced CAR-Th9 therapy efficacy, suggesting that inhibiting this pathway can rejuvenate immune cells and improve treatment success in solid tumor patients.